TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions
Summary: Estrogen receptor-α (ER) drives tumor development in ER-positive (ER+) breast cancer. The transcription factor GATA3 has been closely linked to ER function, but its precise role in this setting remains unclear. Quantitative proteomics was used to assess changes to the ER complex in response...
Main Authors: | Rebecca Broome, Igor Chernukhin, Stacey Jamieson, Kamal Kishore, Evangelia K. Papachristou, Shi-Qing Mao, Carmen Gonzalez Tejedo, Areeb Mahtey, Vasiliki Theodorou, Arnoud J. Groen, Clive D’Santos, Shankar Balasubramanian, Anca Madalina Farcas, Rasmus Siersbæk, Jason S. Carroll |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124721000899 |
Similar Items
-
Global DNA 5hmC and CK19<sup>5hmC+</sup> Contents: A Promising Biomarker for Predicting Prognosis in Small Hepatocellular Carcinoma
by: Jinhua Jiang, et al.
Published: (2021-09-01) -
5-Hydroxymethylcytosine (5hmC), or How to Identify Your Favorite Cell
by: Szilvia Ecsedi, et al.
Published: (2018-01-01) -
5-Hydroxymethylcytosine (5hmC) at or near cancer mutation hot spots as potential targets for early cancer detection
by: Michael J. Lu, et al.
Published: (2022-04-01) -
TET2 Promotes Keloid Hyperplasia by Regulating 5hmC Modification in the TGFβ Promoter Region
by: Niu C, et al.
Published: (2023-04-01) -
TET Enzymes and 5hmC in Adaptive and Innate Immune Systems
by: Chan-Wang J. Lio, et al.
Published: (2019-02-01)